Related Experiment Video
Updated: Aug 16, 2026

Efficient Recombinant Parvovirus Production with the Help of Adenovirus-derived Systems
Published on: April 23, 2012
B19 parvovirus
1Hematology Branch, National Heart, Lung & Blood Institute, Bethesda, MD 20892, USA.
Abstract:
B19 parvovirus is pathogenic in man and causes a variety of clinical illnesses, among them several haematological diseases. Acute infection of a host with underlying haemolysis produces transient aplastic crisis; of the midtrimester fetus, hydrops fetalis; and of an immunocompromised patient, pure red cell aplasia. The target of B19 parvovirus infection is the human erythroid progenitor cell. Infection is cytotoxic due to expression of the viral nonstructural protein. The virus can be propagated in cultures of human bone marrow, blood, and fetal liver. Humoral immunity normally terminates infection, and commercially available immunoglobulin can be used to treat persistent infection. Recombinant capsids, produced in a baculovirus system, are suitable as a vaccine reagent.
Related Concept Videos
Bacterial Gastroenteritis
Poliomyelitis
Rabies
Arboviral Encephalitis
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease

